Alnylam Pharmaceuticals | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Acadia Pharmaceuticals USD 762M 80.42M 2025-06
Agios Pharmaceuticals USD 80.87M 1.91M 2025-06
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Amgen USD 8.03B 782M 2025-06
Arrowhead Research USD 129.79M 55.92M 2025-06
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Incyte USD 2.42B 13.08M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
Moderna USD 1.28B 344M 2025-06
Neurocrine Biosciences USD 264M 69.9M 2025-06
Novartis USD 11.46B 2.15B 2024-12
PTC Therapeutics USD 1.02B 1.01B 2025-06
Regeneron Pharmaceuticals USD 2B 1.09B 2025-06
Sanofi 7.44B 646M 2024-12
Sarepta Therapeutics USD 510.6M 269.73M 2025-06
Takeda JPY 350.01B 35.11B 2025-06
Tectonic Therapeutic USD 141.24M 17.86M 2024-12
Ultragenyx Pharmaceutical USD 166.11M 396.9M 2025-06
Vertex Pharmaceuticals USD 6.38B 1.71B 2025-06
Xencor USD 44.44M 4.77M 2025-06


Alnylam Pharmaceuticals Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.